Literature DB >> 17632002

Synthesis, resolution, and antiplatelet activity of 3-substituted 1(3H)-isobenzofuranone.

Hua Yang1, Gao-Yun Hu, Jun Chen, Yi Wang, Zhong-Hua Wang.   

Abstract

A series of 3-substituted-1(3H)-isobenzofuranone 6a-g and 7a-g were synthesized from phthalic anhydride. The compound 6a-g was resolved. The antiplatelet activities of these compounds were evaluated using in vitro experiment of platelet aggregation. The levels of antiplatelet activity were displayed as following sequence: l-isomer >dl-isomer>d-isomer, respectively. The alkylphthalide is more active than the corresponding alkenephthalide. All these compounds were less active than n-butylphthalide (NBP, 6c) and Aspirin (Asp).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632002     DOI: 10.1016/j.bmcl.2007.06.082

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Isomer-selective distribution of 3-n-butylphthalide (NBP) hydroxylated metabolites, 3-hydroxy-NBP and 10-hydroxy-NBP, across the rat blood-brain barrier.

Authors:  Xing-xing Diao; Kan Zhong; Xiu-li Li; Da-fang Zhong; Xiao-yan Chen
Journal:  Acta Pharmacol Sin       Date:  2015-11-16       Impact factor: 6.150

2.  Sustainable synthesis of 3-substituted phthalides via a catalytic one-pot cascade strategy from 2-formylbenzoic acid with β-keto acids in glycerol.

Authors:  Lina Jia; Fuzhong Han
Journal:  Beilstein J Org Chem       Date:  2017-07-19       Impact factor: 2.883

3.  Discovery of novel West Nile Virus protease inhibitor based on isobenzonafuranone and triazolic derivatives of eugenol and indan-1,3-dione scaffolds.

Authors:  André S de Oliveira; Poliana A R Gazolla; Ana Flávia C da S Oliveira; Wagner L Pereira; Lívia C de S Viol; Angélica F da S Maia; Edjon G Santos; Ítalo E P da Silva; Tiago A de Oliveira Mendes; Adalberto M da Silva; Roberto S Dias; Cynthia C da Silva; Marcelo D Polêto; Róbson R Teixeira; Sergio O de Paula
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.